Regeneron Claims Biocon Drug Mimics Its Patented Medicine
Regeneron Pharmaceuticals has countersued Biocon to block it from infringing on its patents upholding its medication to treat macular degeneration, denying that the Indian pharmaceutical group's formulation would not infringe on...To view the full article, register now.
Already a subscriber? Click here to view full article